Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

NCT04143984
unknownnot_applicable

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

NCT02739659
withdrawnphase_2

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

NCT02946138

Clinical Trials (3)

Showing 3 of 3 trials
NCT04143984Phase 2

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Unknown
NCT02739659Not Applicable

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Unknown
NCT02946138Phase 2

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3